Han Xu, Zhang Wen, Xiang Yi, Teng Mengting, Sun Mei, Liu Peihao
State Key Laboratory of Reproductive Medicine and Offspring Health, Center for Reproductive Medicine, Institute of Women, Children and Reproductive Health, Shandong University, China.; National Research Center for Assisted Reproductive Technology and Reproductive Genetics, Shandong University, Jinan, Shandong, China.; Key Laboratory of Reproductive Endocrinology (Shandong University), Ministry of Education, Jinan, Shandong, China.; Shandong Technology Innovation Center for Reproductive Health, Jinan, Shandong, China.; Shandong Provincial Clinical Research Center for Reproductive Health, Jinan, Shandong, China.; Shandong Key Laboratory of Reproductive Research and Birth Defect Prevention, Jinan, Shandong, China.; Research Unit of Gametogenesis and Health of ART-Offspring, Chinese Academy of Medical Sciences (No. 2021RU001), Jinan, Shandong, China.
State Key Laboratory of Reproductive Medicine and Offspring Health, Center for Reproductive Medicine, Institute of Women, Children and Reproductive Health, Shandong University, China.; National Research Center for Assisted Reproductive Technology and Reproductive Genetics, Shandong University, Jinan, Shandong, China.; Key Laboratory of Reproductive Endocrinology (Shandong University), Ministry of Education, Jinan, Shandong, China.; Shandong Technology Innovation Center for Reproductive Health, Jinan, Shandong, China.; Shandong Provincial Clinical Research Center for Reproductive Health, Jinan, Shandong, China.; Shandong Key Laboratory of Reproductive Research and Birth Defect Prevention, Jinan, Shandong, China.; Research Unit of Gametogenesis and Health of ART-Offspring, Chinese Academy of Medical Sciences (No. 2021RU001), Jinan, Shandong, China..
Reprod Biomed Online. 2025 Aug;51(2):104924. doi: 10.1016/j.rbmo.2025.104924. Epub 2025 Mar 12.
Is there any difference in euploidy rate and outcomes between blastocysts derived from poor- and good-quality day 3 embryos?
This retrospective cohort study included a total of 1492 preimplantation genetic testing for aneuploidies cycles with 12,669 day 3 embryos. These were divided into good- and poor-quality groups based on the morphological quality on day 3. The study compared the blastocyst formation rates between the two groups, as well as the euploidy rate of the blastocysts and the pregnancy outcomes after transferring the euploid blastocysts.
The blastocyst formation rate was significantly higher in the day 3 good-quality group compared with the day 3 poor-quality group (53.6% versus 19.3%, P < 0.001). There was no significant difference in the blastocyst euploidy rate between the two groups (43.8% versus 42.6%, P = 0.150). When euploid blastocysts were transferred, a significant difference was observed in the biochemical pregnancy rate between the two groups (68.8% versus 76.3%, P = 0.028), while no significant differences were found in the clinical pregnancy rate (61.4% versus 66.7%, P = 0.143), miscarriage rate (15.1% versus 18.4%, P = 0.317), ectopic pregnancy rate (0.5% versus 0.0%, P = 0.587) and live birth rate (51.4% versus 53.5%, P = 0.562).
Day 3 embryo quality significantly influenced blastocyst formation rate, but did not affect either blastocyst euploidy or pregnancy outcomes. This indicates that once embryos can develop into transferrable blastocysts, their quality may be considered to be of a comparable level regardless of the morphology of their cleavage stage.
来自质量差和质量好的第三天胚胎的囊胚在整倍体率和结局方面是否存在差异?
这项回顾性队列研究共纳入了1492个非整倍体植入前基因检测周期,涉及12,669个第三天胚胎。根据第三天的形态质量将这些胚胎分为质量好和质量差两组。该研究比较了两组之间的囊胚形成率,以及囊胚的整倍体率和移植整倍体囊胚后的妊娠结局。
第三天质量好的组的囊胚形成率显著高于第三天质量差的组(53.6%对19.3%,P<0.001)。两组之间的囊胚整倍体率无显著差异(43.8%对42.6%,P = 0.150)。当移植整倍体囊胚时,两组之间的生化妊娠率存在显著差异(68.8%对76.3%,P = 0.028),而临床妊娠率(61.4%对66.7%,P = 0.143)、流产率(15.1%对18.4%,P = 0.317)、异位妊娠率(0.5%对0.0%,P = 0.587)和活产率(51.4%对53.5%,P = 0.562)均无显著差异。
第三天胚胎质量显著影响囊胚形成率,但不影响囊胚整倍体率或妊娠结局。这表明,一旦胚胎能够发育成可移植的囊胚,无论其卵裂期的形态如何,其质量可能被认为处于可比水平。